Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Whitehead

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Statistics in Medicine|January 3, 2013
Designing exploratory cancer trials using change in tumour size as primary endpointThomas Jaki, Valérie André, Ting-Li Su, et al.
Statistics in Medicine|September 22, 2007
Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methodsAnne Whitehead, Marina Roshini Sooriyarachchi, John Whitehead, et al.
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
Statistics in Medicine|June 25, 2014
Bayesian methods for the design and interpretation of clinical trials in very rare diseasesLisa V Hampson, John Whitehead, Despina Eleftheriou, et al.
Statistics in Medicine|December 5, 2008
Updating our aims and scope for the futureRalph B D'Agostino, Vern Farewell, Joel B Greenhouse, et al.
Statistics in Medicine|November 19, 2004
Design considerations in the sequential analysis of matched case-control dataM Fazil Baksh, Susan Todd, John Whitehead, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpointsJohn Whitehead, Yinghui Zhou, Lisa Hampson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2023
Perspectives on valuing water quality improvements using stated preference methodsIan J Bateman, Bonnie Keeler, Sheila M Olmstead, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|January 3, 2013
Designing exploratory cancer trials using change in tumour size as primary endpointThomas Jaki, Valérie André, Ting-Li Su, et al.
Statistics in Medicine|September 22, 2007
Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methodsAnne Whitehead, Marina Roshini Sooriyarachchi, John Whitehead, et al.
Pharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.
Statistics in Medicine|June 25, 2014
Bayesian methods for the design and interpretation of clinical trials in very rare diseasesLisa V Hampson, John Whitehead, Despina Eleftheriou, et al.
Statistics in Medicine|December 5, 2008
Updating our aims and scope for the futureRalph B D'Agostino, Vern Farewell, Joel B Greenhouse, et al.
Statistics in Medicine|November 19, 2004
Design considerations in the sequential analysis of matched case-control dataM Fazil Baksh, Susan Todd, John Whitehead, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpointsJohn Whitehead, Yinghui Zhou, Lisa Hampson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2023
Perspectives on valuing water quality improvements using stated preference methodsIan J Bateman, Bonnie Keeler, Sheila M Olmstead, et al.
Pageof 8